RecruitingPhase 3NCT07174310
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Sponsor: Hoffmann-La Roche
Canton, OH · Cleveland, OH · +51 more sites
3 recruiting parkinson's disease studies with a site in Canton, OH.
Sponsor: Hoffmann-La Roche
Canton, OH · Cleveland, OH · +51 more sites
Sponsor: Vima Therapeutics
Canton, OH · +28 more sites
Sponsor: Impax Laboratories, LLC
Canton, OH · Cincinnati, OH · Cleveland, OH · +24 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.